Sydney, NSW (PRWEB) August 1, 2008
Australia's Best Manufacturing was released late July 2008 and included an in-deph editorial on ResMed.
At ResMed, the primary company focus is on continuous innovation to develop breakthrough products and technologies. As global leaders in sleep and respiratory medicine, ResMed educate and raise awareness by sharing knowledge with patients, clinicians, industry professionals and the broader medical community. The result of this is an ongoing journey of growth, leadership and excellence.
When ResMed was formed in 1989, their primary purpose was to commercialize a device for treating obstructive sleep apnea (OSA), a major subset of SDB. Developed in 1981 by Professor Colin Sullivan and colleagues at the University of Sydney, nasal continuous positive airway pressure (CPAP) provided the first successful non-invasive treatment of OSA. Since that time, ResMed have remained focused on SDB, which is gaining greater public and physician awareness. Operations have grown dramatically through the introduction of a number of highly innovative product lines. In 2007 Resmed delivered a record six new products in a single year.
Building on the strength of their existing portfolio has broadened the company's market share for flow generators at both ends of the spectrum. ResMed now operates in over 65 countries via direct offices and a network of distributors with extensive knowledge and experience of local markets.
"Significant annual volume growth since ResMed's beginnings in1989, and the need to manage an increasing number of purchased components and suppliers, has resulted in the formation of a Procurement and Supplier Alliance function to manage ResMed's global sourcing activities.
Managing a supply chain that supports innovation and product development functions, as well as several global manufacturing facilities and a global customer base requires efficient and responsive supplier partners and service providers. ResMed has commenced the process of transformational change from the traditional 'buyer/seller' relationship with suppliers to creating and maintaining strategic supplier alliances or partnerships.
"The development and manufacture of medical device products requires manufacturers to operate in a highly regulated environment. The process of researching, selecting and engaging supply partners is based on ResMed's QDC strategy (quality, delivery and cost). This strategy is critical to ensuring an understanding of ResMed's minimum expectations from a supplier alliance partner and the importance of creating a sustainable advantage in the increasingly competitive medical device market.
"These imperatives drive the need for a supply base that will provide sustained support for innovative product development, quality and process improvements and cost reduction initiatives. A practical example of ResMeds' supplier alliance program in practice is 'early supplier involvement' in the product development process. Time to market is critical and the earlier a key supplier is involved in the design and development of components, the more likely the success of achieving project deliverables. Similarly, regular business meetings to review topics such as technology development, process improvements, quality management, capital investment, people development and cost reduction opportunities are considered essential in developing a collaborative partnership."